Making Biostarks an AI native at-home biomarker testing company
This is the first in a series of articles on how we are designing and operating Biostarks in the age of AI. Not a manifesto — a working account of what we are actually building.
When we completed the acquisition of Biostarks in summer 2025, AI for the organisation meant mostly
